Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anal Canal Carcinoma × Platinum × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 8 Pancreatic Neoplasms 5 Cholangiocarcinoma 5 Ovarian Neoplasms 4 Gallbladder Neoplasms 4 Esophageal Neoplasms 4 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Sarcoma 2 Rectal Neoplasms 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Carcinoma, Hepatocellular 2 Anus Neoplasms 2 Uterine Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rhabdomyosarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Pelvic Neoplasms 1 PRETEXT I Hepatoblastoma 1 Mesothelioma, Malignant 1 Liposarcoma 1 Klatskin Tumor 1 Hepatoblastoma 1 Gastrointestinal Neoplasms 1 Gastric Adenocarcinoma 1 Fibrolamellar hepatocellular carcinoma 1 Fallopian Tube Neoplasms 1

Interventions

Fluorouracil 8 Cisplatin 7 Radiotherapy 6 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiotherapy, Intensity-Modulated 3 Mitomycin 3 Capecitabine 3 dehydroftorafur 2 Radiation 2 Nivolumab 2 Cetuximab 2 Biopsy 2 toripalimab 1 pembrolizumab 1 atezolizumab 1 X-Rays 1 Watchful Waiting 1 Vaccines 1 Taxes 1 Sigmoidoscopy 1 Radiosurgery 1 Proctoscopy 1 Platinum 1 Phantoms, Imaging 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Mitozytrex 1 Mitomycins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡